|
Basic characteristics
|
|
Age, per 1 year increment
|
1.029 (1.026–1.032)
|
< 0.001
|
1.019 (1.016–1.022)
|
< 0.001
|
|
Male gender
|
1.296 (1.184–1.419)
|
< 0.001
|
1.167 (1.063–1.281)
|
0.001
|
|
Body mass index, pre 1 increment
|
0.947 (0.937–0.956)
|
< 0.001
|
0.955 (0.946–0.965)
|
< 0.001
|
|
Comorbidities
|
|
Diabetes mellitus
|
1.292 (1.176–1.419)
|
< 0.001
|
1.171 (1.062–1.291)
|
0.001
|
|
Congestive heart failure
|
1.272 (1.100–1.470)
|
0.001
|
1.370 (1.172–1.601)
|
< 0.001
|
|
Chronic pulmonary disease
|
1.819 (1.482–2.232)
|
< 0.001
|
1.166 (0.942–1.442)
|
0.158
|
|
Moderate or severe liver disease
|
2.002 (1.635–2.452)
|
< 0.001
|
1.326 (1.077–1.633)
|
0.008
|
|
End-stage renal disease
|
1.841 (1.299–2.610)
|
< 0.001
|
1.434 (1.007–2.042)
|
0.046
|
|
Malignancy
|
2.435 (2.227–2.663)
|
< 0.001
|
2.155 (1.929–2.408)
|
< 0.001
|
|
Presence of metastatic tumour
|
3.728 (3.198–4.344)
|
< 0.001
|
4.553 (3.867–5.360)
|
< 0.001
|
|
Types of surgery
|
|
Cardiovascular surgery
|
Reference
| |
Reference
| |
|
Neurosurgery
|
1.454 (1.266–1.670)
|
< 0.001
|
1.410 (1.207–1.647)
|
< 0.001
|
|
Major abdominal surgery
|
4.013 (3.448–4.671)
|
< 0.001
|
1.527 (1.276–1.828)
|
< 0.001
|
|
Severity and managements
|
|
APACHE II, per 1 increment
|
1.115 (1.107–1.123)
|
< 0.001
|
1.064 (1.056–1.073)
|
< 0.001
|
|
Presence of shock
|
1.994 (1.831–2.172)
|
< 0.001
|
1.401 (1.273–1.542)
|
< 0.001
|
|
Receiving mechanical ventilation
|
2.300 (2.115–2.501)
|
< 0.001
|
1.079 (0.969–1.201)
|
0.166
|
|
Fluid overload, days 1–3, per 1-L increment
|
1.104 (1.087–1.120)
|
< 0.001
|
1.031 (1.016–1.047)
|
< 0.001
|
|
Receiving renal replacement therapy
|
4.372 (3.831–4.989)
|
< 0.001
|
1.966 (1.693–2.284)
|
< 0.001
|
|
Positive culture during admission
|
2.842 (2.614–3.091)
|
< 0.001
|
1.579 (1.422–1.754)
|
< 0.001
|
